Conference abstract
In silico studies of DRD2 gene structural variant (Ser311Cys) binding to Risperidone for schizophrenia treatment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
As an antipsychotic drug which has been increasingly used for treatment and maintenance therapy in schizophrenia, Risperidone has potent antagonistic properties for the dopamine D2 receptor. As a complex and severe disorder affecting 1% of the population, with high heritability nearly 80%, schizophrenia is strongly involved with genetic factors including functional polymorphisms. The tertiary structures of human DRD2 protein in wild-type (Ser311) and mutant (Cys311) alleles of rs1801028 (C>G) were modeled by the chosen template (PDB ID: 6CM4) through SWISS-MODEL. Then, opted models were built after energy minimization by Swiss-PdbViewer ver. 4.1.0 software. The structures of dominant and recessive models were then validated using ERRAT (Errat value: 94.97 and 90.35, respectively), RAMPAGE (Number of residue in favored region: 93.8 and 93.3, respectively) and ProSA (z-score: -6 and -2.48, respectively) online softwares. To prepare Risperidone, energy minimization was performed using Hyperchem professional tool ver. 8.0.8. Active site of DRD2 was predicted by COACH. By Autodock ver. 1.5.6., best conformation was opted based on the lowest binding energy and H-Bonds in cluster. In silico analyses of DRD2 protein with Risperidone represented that the best conformation of Risperidone had more binding affinity to Ser311 (binding Energy=-11.23 kcal/mol with 2 Hydrogen bonds formation) compared to Cys311 model (binding Energy=-10.78 kcal/mol with 1 H-bond formation). Considering clinical response and side effects of Risperidone, optimizing drug treatment for patient is often by trial and error which costs a lot of time and money, so genotyping of Ser311Cys might be a novel SNP marker to predict Risperidone response and C allele carriers (Ser311) could receive lower doses compared to G allele carriers.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiochemistry & Molecular Biology Journal
- SubjectBiochemistry & Biotechnology
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Alireza Sharafshah”
- BylineArticles whose byline prints “Mohammad Raad”